Success Story: Cancer Biology Researcher Secures NIW Approval After RFE
Client’s Testimonial:
"Thank you for the wonderful news! I am very happy with the approval and truly appreciate all the work and support from your team throughout the NIW process.”
On August 27th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Scholar in the Field of Cancer Biology (Approval Notice).
General Field: Cancer Biology
Position at the Time of Case Filing: Postdoctoral Scholar
Country of Origin: China
State of Residence at the Time of Filing: Kentucky
Approval Notice Date: August 27th, 2026
Processing Time: 5 months, 14 days (Premium Processing Upgrade Requested)
Case Summary:
Cancer remains a major health challenge, particularly when tumors progress or become resistant to available treatments. Against this backdrop, the client pursued an EB-2 National Interest Waiver (NIW) based on her work in cancer biology. Holding a Ph.D. in surgery, the client was conducting research at a U.S. university at the time of the petition, where her work focused broadly on understanding cancer progression and treatment resistance. Her proposed endeavor was to continue investigating the biological mechanisms involved in these processes and identifying markers that may contribute to improved cancer diagnosis, treatment strategies, and clinical outcomes.
In presenting the national importance of this endeavor, the petition connected the client’s research to the broader health and economic burden associated with cancer in the United States. Her work seeks to improve understanding of why certain cancers progress or resist treatment, with the longer-term goal of supporting more effective and personalized therapeutic approaches. We also highlighted that research advancing her proposed endeavor had received support from major U.S. federal funding sources, including the National Institutes of Health and the Department of Defense, providing additional evidence that work in this area aligns with significant national research priorities.
To establish that the client was well positioned to advance her endeavor, the petition presented a combination of her education, research experience, publication record, scholarly influence, and continued research plans. She had documented her findings in 13 peer-reviewed journal articles, including 6 first-authored papers, as well as 2 abstracts and 2 preprints. Her published work had accumulated 70 citations. Rather than relying on the citation total alone, the petition examined the relative citation performance of individual papers and showed that several ranked among highly cited works from comparable publication years and research categories. This contextual evidence helped demonstrate that researchers in the field were engaging with and building upon her findings.
The petition further illustrated the client’s significance through concrete examples of independent researchers using her work in subsequent studies concerning cancer progression, treatment resistance, and therapeutic response. This evidence was important because it demonstrated practical scholarly influence beyond publication numbers alone. In addition, the client had completed at least 16 peer reviews for scholarly publications. Her invitations to assess other researchers’ work provided another indicator that her expertise was recognized within the scientific community and that she was trusted to contribute to the evaluation and advancement of research in her field.
Following an RFE, the case ultimately received I-140 NIW approval. The petition’s overall strategy was to show how the different parts of the client’s record reinforced one another: her advanced training established a strong technical foundation, her publication and citation record documented sustained research activity and influence, independent use of her findings demonstrated broader relevance, peer-review service reflected recognition of her expertise, and federally supported research underscored the importance of the area in which she works. Together with her ongoing cancer biology research, this evidence supported the position that the client was well positioned to continue an endeavor with substantial merit and national importance to the United States.